Published November 17, 2022 | Version v1
Journal article Restricted

Supplementary File:Metformin inhibits the progression of prostate cancer by in-ducing purine metabolic alters and enhancing the PDE6D / cGMP / PKG pathway

Creators

  • 1. The First Affiliated Hospital of Guangzhou Medical University

Description

Supplementary Materials: Table S1: Significant altered metabolites between the metformin (+) group and metformin (-) group in positive mode.; Table S2: Significant altered metabolites between the metformin (+) group and metformin (-) group in negative mode.; Table S3: Differential expressed genes between the metformin (+) group and metformin (-) group.File S4: Untargeted metabolomic sequencing data.

Files

Restricted

The record is publicly accessible, but files are restricted to users with access.